Extrapulmonary sarcoidosis during antiviral therapy for chronic hepatitis C

The spectrum of adverse reactions caused by combined interferon therapy includes the development of autoimmune diseases, including sarcoidosis. Extrapulmonary sarcoidosis is its rare form. The paper describes a case of extrapulmonary sarcoidosis in a young woman at 28 weeks of combined interferon therapy for chronic hepatitis C 1b genotype. Corticosteroid therapy led to remission with the retention of a sustained virological response to antiviral therapy.